Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$1.32 - $4.83 $654 - $2,395
496 Added 2.55%
19,946 $27,000
Q3 2023

Nov 13, 2023

SELL
$3.02 - $4.05 $14,550 - $19,512
-4,818 Reduced 19.85%
19,450 $59,000
Q2 2023

Aug 11, 2023

BUY
$2.79 - $5.03 $92 - $165
33 Added 0.14%
24,268 $79,000
Q1 2023

May 12, 2023

SELL
$3.14 - $8.22 $2,298 - $6,017
-732 Reduced 2.93%
24,235 $77,000
Q4 2022

Feb 10, 2023

BUY
$5.77 - $8.49 $3,335 - $4,907
578 Added 2.37%
24,967 $172,000
Q3 2022

Nov 14, 2022

BUY
$3.75 - $7.39 $91,458 - $180,234
24,389 New
24,389 $154,000
Q2 2021

Aug 13, 2021

SELL
$18.04 - $22.09 $579,372 - $709,442
-32,116 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$16.59 - $33.89 $820,674 - $1.68 Million
-49,468 Reduced 60.63%
32,116 $968,000
Q4 2020

Feb 10, 2021

BUY
$27.5 - $37.92 $27,307 - $37,654
993 Added 1.23%
81,584 $3.53 Million
Q3 2020

Nov 12, 2020

BUY
$34.44 - $43.75 $6,199 - $7,875
180 Added 0.22%
80,591 $4.35 Million
Q2 2020

Aug 13, 2020

BUY
$27.12 - $45.97 $14,292 - $24,226
527 Added 0.66%
80,411 $5.25 Million
Q1 2020

May 13, 2020

BUY
$26.16 - $63.5 $17,893 - $43,434
684 Added 0.86%
79,884 $3.67 Million
Q4 2019

Feb 12, 2020

SELL
$46.96 - $61.67 $3.26 Million - $4.29 Million
-69,500 Reduced 46.74%
79,200 $6.95 Million
Q4 2018

Feb 12, 2019

SELL
$59.1 - $93.26 $13.9 Million - $21.9 Million
-234,478 Reduced 61.19%
148,700 $14.8 Million
Q3 2018

Nov 13, 2018

SELL
$88.86 - $117.49 $464,026 - $613,532
-5,222 Reduced 1.34%
383,178 $55.9 Million
Q2 2018

Aug 14, 2018

BUY
$99.64 - $127.59 $687,516 - $880,371
6,900 Added 1.81%
388,400 $61 Million
Q1 2018

May 10, 2018

SELL
$105.8 - $150.94 $32.3 Million - $46.1 Million
-305,400 Reduced 44.46%
381,500 $65.1 Million
Q4 2017

Feb 14, 2018

BUY
$81.25 - $130.7 $16.3 Million - $26.3 Million
200,900 Added 41.34%
686,900 $122 Million
Q3 2017

Nov 13, 2017

BUY
$57.74 - $91.42 $28.1 Million - $44.4 Million
486,000
486,000 $66.8 Million

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $23.1M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.